Skip to content

Clinical trials

No longer available Multiple Myeloma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Status: No longer available Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
Janssen Research & Development, LLC3
Novartis Pharmaceuticals2
Pfizer2
Barbara Ann Karmanos Cancer Institute1
Celgene1
Dana-Farber Cancer Institute1
Genzyme, a Sanofi Company1
Janssen-Ortho Inc., Canada1
Masonic Cancer Center, University of Minnesota1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma20
Recurrence6
Hodgkin Disease2
Lymphoma, Non-Hodgkin2
Blast Crisis1
Burkitt Lymphoma1
Congenital Abnormalities1
Dendritic Cell Sarcoma, Interdigitating1
Immunoglobulin Light-chain Amyloidosis1
Leukemia1

Trials

Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.